Malenka Robert C. 4

4 · MapLight Therapeutics, Inc. · Filed Feb 12, 2026

AI-generated summary of this filing

Updated Feb 12, 2026

MapLight Therapeutics (MPLT) Director Robert Malenka Sells Shares

What Happened

Robert C. Malenka, a director of MapLight Therapeutics, sold a total of 6,863 shares in two open-market transactions on Feb 10–11, 2026. He disposed of 6,622 shares at an average of $18.12 (proceeds $119,991) and 241 shares at $18.00 (proceeds $4,338), for combined proceeds of about $124,329.
The filing indicates these sales were made to cover tax obligations arising from the settlement of restricted stock units (RSUs), not an independent open-market investment decision.

Key Details

Transaction dates & prices: Feb 10, 2026 — 6,622 shares at a weighted avg price $18.12; Feb 11, 2026 — 241 shares at $18.00. Reported price range across all trades: $18.00–$18.41.
Total sold: 6,863 shares for approximately $124,329. The filing reports a weighted average sales price.
Reason: Sales were to cover tax withholding on RSU settlement (each RSU converts to one share). (Footnote F1)
Holdings: Remaining shares are held by the Robert C. Malenka Living Trust (the reporting person is sole trustee with voting and dispositive power). (Footnote F3)
Lock-up: The filing notes the Reporting Person agreed to a 180‑day IPO lock-up (final prospectus dated Oct 26, 2025); retained securities remain subject to that lock-up, subject to certain exceptions. (Footnote F1)
Filing: Form 4 filed Feb 12, 2026. The filing does not indicate a late report.

Context

These were sales (S) tied to tax withholding on RSU settlement — a common administrative reason insiders sell shares and not necessarily an indicator of the insider’s view on the company.
RSUs: Each restricted stock unit represents a contingent right to receive one share upon settlement; the sold shares were used to satisfy the related tax obligations.

Form 4

Period: 2026-02-10

Director

Transactions

Sale
Voting Common Stock
[F1][F2]
2026-02-10$18.12/sh−6,622$119,991→ 351,611 total
Sale
Voting Common Stock
[F1]
2026-02-11$18.00/sh−241$4,338→ 351,370 total

Holdings

Footnotes (3)

[F1]Represents sales of shares of common stock by the Reporting Person to cover tax obligations in connection with the settlement of restricted stock unit awards. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. The securities of the Issuer retained by the Reporting Person remain subject to the terms a lock-up agreement entered into with the underwriters for the Issuer's initial public offering, pursuant to which the Reporting Person agreed, subject to certain exceptions, not to directly or indirectly sell or otherwise transfer securities of the Issuer for a period of 180 days following the date of the final prospectus relating to the initial public offering, which was October 26, 2025.
[F2]The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F3]The shares are held by the Robert C. Malenka Living Trust U/A DTD 08/21/2012, of which the Reporting Person is the sole trustee and has voting and dispositive power.

Signature

/s/ Kristopher L. Hanson, Attorney-in-Fact|2026-02-12

1 file